Viewing nowCombinationHanwha Rokkan Tablets 5/16mg (Rosuvastatin Calcium, Candesartan Cilexetil)
Rosuvastatin Calcium 5.2mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanwha Pharmaceutical Co., Ltd.

MFDS item code 202301660 · Approved 2023.05.24 · Insurance code 651602930
Treatment of dyslipidemia, hypertension, and heart failure; inhibition of atherosclerosis progression and cardiovascular disease risk
This medication is used for patients who need to take both Candesartan Cilexetil and Rosuvastatin. Candesartan Cilexetil is primarily used for the treatment of essential hypertension, and it helps patients with heart failure with decreased left ventricular function, either in combination with ACE inhibitors or for those who cannot take ACE inhibitors. Rosuvastatin is used as an adjunctive treatment to lower cholesterol levels in patients with hypercholesterolemia and mixed dyslipidemia when dietary measures are insufficient. It also helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in patients at high risk of cardiovascular disease. This medication is used to manage hypertension, hyperlipidemia, and the risk of cardiovascular disease together, improving the patient's overall health status.
This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil/rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful caution in patients at increased risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose in patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose in patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout treatment. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this drug to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience in patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. 5. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligram dose of this drug is contraindicated in some of these patients. For patients taking candesartan cilexetil and rosuvastatin concomitantly, they may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience.
Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.
This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so discontinuation is necessary as soon as pregnancy is confirmed. It is safe not to administer this medication to patients with poor liver function, severe kidney impairment, or muscular disorders. Elderly patients, patients with hyperkalemia, and those with mild to moderate liver impairment should be carefully monitored during administration, and regular assessments of liver and kidney function are necessary. If symptoms such as muscle pain or muscle weakness occur, inform a doctor immediately, and if necessary, test muscle enzyme levels and discontinue use if abnormalities are found. This medication may interact with other antihypertensive drugs or certain lipid-lowering agents, so inform healthcare providers of any other medications being taken. Women of childbearing potential should use appropriate contraception, and breastfeeding women are advised to avoid this medication; if use is unavoidable, breastfeeding should be stopped. Caution is needed when driving or operating machinery, as dizziness or fatigue may occur.
Headache, nasopharyngitis, localized infection, chest discomfort, fatigue, inflammation, generalized pruritus, dermatitis, itching, joint stiffness, musculoskeletal pain, neck pain, limb pain, cataract, photophobia, dyspepsia, nausea, elevated blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, tooth extraction, postural dizziness, dizziness, hepatoid cyst, periodontitis, angioedema, low back pain, respiratory infection, asthenia, fever, paresthesia, dyspepsia, gastroenteritis, tachycardia, palpitations, increased creatine kinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, epistaxis, anxiety, depression, drowsiness, dyspnea, rash, increased sweating, hematuria, leukopenia, neutropenia, agranulocytosis, hyperkalemia, hyponatremia, hypoglycemia, vertigo, intestinal vascular edema, increased liver enzyme levels, hepatitis, elevated AST, elevated ALT, increased γ-GTP, jaundice, rash, urticaria, angioedema, rhabdomyolysis, arthralgia, myalgia, low back pain, renal impairment, acute renal failure, interstitial pneumonia, shock, syncope, loss of consciousness, paralysis, hypertonia, syncope, facial flushing, weight gain, facial edema, thirst, sleep disturbances, decreased libido, amnesia, anorexia, increased appetite, tinnitus, taste disorder, erectile dysfunction, constipation, abdominal pain, pancreatitis, myopathy, myositis, angioedema, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbance, interstitial lung disease, fatal liver failure, non-fatal liver failure, cognitive impairment, severe myasthenia gravis, ocular myasthenia gravis, hypotension, hyperkalemia, renal impairment, increased creatinine, elevated urea, increased potassium, decreased sodium, elevated ALT, increased CK, arthralgia, numbness, sensory disturbances, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1°C and 30°C. This will help maintain the drug's efficacy and safety for a longer time.
Pink round film-coated tablets
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanwha Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.